Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VinCaP: Vinflunine in advanced penile carcinoma
NCT02057913Phase 2Completed
- Sponsor
- The Institute of Cancer Research
- Start
- Mar 2014
- Primary completion
- Nov 2018
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinflunine in penile squamous cell carcinoma (PSCC), sponsored by The Institute of Cancer Research. Started Mar 2014; status: completed.
02
Drugs
vinflunine
03
Conditions
penile squamous cell carcinoma (PSCC)
Beyond the preview
Go deeper on NCT02057913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02057913.